Information for Health Care Professionals
Around 10% of pancreatic cancer cases are linked to inherited factors. These occur in families with a history of either pancreatic cancer or hereditary pancreatitis or who carry an at-risk genetic mutation predisposing to these conditions. NICE guidance (NG85) recommends surveillance for people with an inherited high-risk ideally to detect pancreatic cancer earlier.
EUROPAC’s aim is to develop early detection methods for pancreatic cancer, by better understanding risk and offering surveillance to those who take part and to continuously refine who to and how we provide surveillance to individuals.
NHS England is working with EUROPAC to provide a route from the NHS into their national surveillance program run at NHS Trusts across the country for people who may be at high risk of pancreatic cancer.
Who can you refer?
Save Your Spot
Cheshire and Merseyside Cancer Alliance are working collaboratively with EUROPAC to improve surveillance for people who may be at a higher risk of developing pancreatic cancer.
To support this, a monthly session has been set up for any healthcare professional to join if they have any queries about referral eligibility for participants. The open sessions can be accessed by RSVP below.